Sfoglia per AUTORE
LOCONSOLE F
Collezione ASL Torino 4
Items : 2
Tildrakizumab and Quality of Life: Deep Dive into the Impact of Psoriasis and Treatment on Different Domains-Should Psychosocial Life Impairment Be Considered a Comorbidity? in Journal of clinical medicine / J Clin Med. 2025 Jan 2;14(1):223. doi: 10.3390/jcm14010223.
2025
ASL Torino 4
AOU Città della Salute di Torino
ASL Torino 4
AOU Città della Salute di Torino
Faure E; Papaianni V; Giordano D; Galdo G; Cerulli E; Zanetta R; Siliquini N; Solaroli C; Peila R; De Col E; Richetta AG; Dattola A; Stroppiana E; Giuffrida G; Castelli F; Di Brizzi EV; Licata G; Pertusi G; Uzzauto MT; Loconsole F; Zichichi L;
Assessing the Beneficial Impact of a Patient Support Program in Secukinumab-Treated Patients with Psoriasis in Italy. in Patient preference and adherence / Patient Prefer Adherence. 2021 Nov 19;15:2551-2562. doi: 10.2147/PPA.S326498. eCollection 2021.
2021
ASL Alessandria
ASL Torino 4
AOU Novara
ASL Alessandria
ASL Torino 4
AOU Novara
Uzzauto MT; Travaglini M; Tiberio R; Richetta AG; Savoia P; Peris K; Malara G; Loconsole F; Leporati C; Lembo S; Giofrè C; Foti C; De Pasquale R; Fargnoli MC; Coppola S; Costanzo A; Castelli G; Baggini G; Baldari M; Aragone MG; Amerio P; Argenziano G; Bianchi L;